Causal network models of SARS-CoV-2 expression and aging to identify candidates for drug repurposing
Given the severity of the SARS-CoV-2 pandemic, a major challenge is to rapidly repurpose existing approved drugs for clinical interventions. Here, the authors identify robust druggable protein targets within a principled causal framework that makes use of multiple data modalities and integrates agin...
Guardado en:
Autores principales: | Anastasiya Belyaeva, Louis Cammarata, Adityanarayanan Radhakrishnan, Chandler Squires, Karren Dai Yang, G. V. Shivashankar, Caroline Uhler |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0070bbeebfbc43a1a7a2f2bff257da7c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Multi-domain translation between single-cell imaging and sequencing data using autoencoders
por: Karren Dai Yang, et al.
Publicado: (2021) -
Machine learning identifies candidates for drug repurposing in Alzheimer’s disease
por: Steve Rodriguez, et al.
Publicado: (2021) -
A comprehensive SARS-CoV-2 genomic analysis identifies potential targets for drug repurposing.
por: Nithishwer Mouroug Anand, et al.
Publicado: (2021) -
A drug repurposing screen identifies hepatitis C antivirals as inhibitors of the SARS-CoV2 main protease.
por: Jeremy D Baker, et al.
Publicado: (2021) -
Strategies to identify candidate repurposable drugs: COVID-19 treatment as a case example
por: Ali S. Imami, et al.
Publicado: (2021)